BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND GRIN2A, Q12879, 2903, ENSG00000183454, NMDAR2A, NR2A AND Prognosis
3 results:

  • 1. Prognostic and predictive value of a microRNA signature in adults with T-cell lymphoblastic lymphoma.
    Tian XP; Huang WJ; Huang HQ; Liu YH; Wang L; Zhang X; Lin TY; Rao HL; Li M; Liu F; Zhang F; Zhong LY; Liang L; Lan XL; Li J; Liao B; Li ZH; Tang QL; Liang Q; Shao CK; Zhai QL; Cheng RF; Sun Q; Ru K; Gu X; Lin XN; Yi K; Shuang YR; Chen XD; Dong W; Sang W; Sun C; Liu H; Zhu ZG; Rao J; Guo QN; Zhou Y; Meng XL; Zhu Y; Hu CL; Jiang YR; Zhang Y; Gao HY; He WJ; Xia ZJ; Wu CL; Zhang MY; Wang HY; Xie D; Cai QQ
    Leukemia; 2019 Oct; 33(10):2454-2465. PubMed ID: 30953029
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. BIM deletion polymorphism accounts for lack of favorable outcome in Japanese females with follicular lymphoma.
    Ito Y; Umezu T; Tadokoro K; Saito Y; Katagiri S; Suguro T; Asano M; Yoshizawa S; Akahane D; Tanaka Y; Fujimoto H; Okabe S; Gotoh M; Tauchi T; Kawana C; Ohyashiki JH; Nakamura N; Ohyashiki K
    Leuk Lymphoma; 2019 May; 60(5):1283-1288. PubMed ID: 30480474
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.
    Okayama H; Kohno T; Ishii Y; Shimada Y; Shiraishi K; Iwakawa R; Furuta K; Tsuta K; Shibata T; Yamamoto S; Watanabe S; Sakamoto H; Kumamoto K; Takenoshita S; Gotoh N; Mizuno H; Sarai A; Kawano S; Yamaguchi R; Miyano S; Yokota J
    Cancer Res; 2012 Jan; 72(1):100-11. PubMed ID: 22080568
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.